Work

HSR25-187: Meta-Analysis of Phase III Randomized Controlled Trials to Evaluate the Risk of Gastrointestinal Adverse Events in Patients With EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) Treated With Amivantamab

Year: 2025

Type: review

Study designs: Systematic Review, Meta-Analysis

Source: Journal of the National Comprehensive Cancer Network

DOI: 10.6004/jnccn.2024.7317

Authors: Riccesha Hattin, Hazem Aboaid, Abbas Hussain, Savannah Schauer, Tal Schlesinger, Rory Twells, Karl Aharonian, Ryan Parto, Rodd Rahmani, Chalette Lambert-Swainston, Daniel Thomas Jones, Ramaditya Srinivasmurthy, Kyaw Zin Thein

Institutions: University of Nevada, Las Vegas, Touro University Nevada, Comprehensive Cancer Centers of Nevada

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4408940572

FWCI:

Cites:

Cited by:

Related to: 10